Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug development research in pregnant and lactating women
Zhaoxia Ren, Andrew A. Bremer, Aaron C. Pawlyk
American Journal of Obstetrics and Gynecology (2021) Vol. 225, Iss. 1, pp. 33-42
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

The immunobiology of preterm labor and birth: intra-amniotic inflammation or breakdown of maternal–fetal homeostasis
Nardhy Gómez-López, José Galaz, Derek Miller, et al.
Reproduction (2022) Vol. 164, Iss. 2, pp. R11-R45
Open Access | Times Cited: 85
Macronutrients in Human Milk Exposed to Antidepressant and Anti-Inflammatory Medications
Essi Heinonen, Kerri Bertrand, Christina Chambers
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2453332-e2453332
Open Access | Times Cited: 2
COVID-19 Vaccine Acceptance of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-Sectional Study
Abanoub Riad, Anna Jouzová, Batuhan Üstün, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 24, pp. 13373-13373
Open Access | Times Cited: 91
Delivery technologies for women’s health applications
Kelsey L. Swingle, Adele S. Ricciardi, William H. Peranteau, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 6, pp. 408-425
Open Access | Times Cited: 29
Off-Label Use vs Off-Label Marketing of Drugs
Gail A. Van Norman
JACC Basic to Translational Science (2023) Vol. 8, Iss. 2, pp. 224-233
Open Access | Times Cited: 21
Factors influencing the participation of pregnant and lactating women in clinical trials: A mixed-methods systematic review
Mridula Shankar, Alya Hazfiarini, Rana Islamiah Zahroh, et al.
PLoS Medicine (2024) Vol. 21, Iss. 5, pp. e1004405-e1004405
Open Access | Times Cited: 8
The drug drought in maternal health: an ongoing predicament
Anne Ammerdorffer, Annie R.A. McDougall, Andrew Tuttle, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 7, pp. e1174-e1183
Open Access | Times Cited: 6
Determining the exposure of maternal medicines through breastfeeding: the UmbrelLACT study protocol—a contribution from the ConcePTION project
Martje Van Neste, Nina Nauwelaerts, Michael Ceulemans, et al.
BMJ Paediatrics Open (2024) Vol. 8, Iss. 1, pp. e002385-e002385
Open Access | Times Cited: 5
Watermelon‐Derived Extracellular Vesicles Influence Human Ex Vivo Placental Cell Behavior by Altering Intestinal Secretions
Kate Timms, Beth Holder, Anil Day, et al.
Molecular Nutrition & Food Research (2022) Vol. 66, Iss. 19
Open Access | Times Cited: 21
Concentrations of antiseizure medications in breast milk of lactating women with epilepsy: A systematic review with qualitative synthesis
Ramzi Shawahna, Lina Zaid
Seizure (2022) Vol. 98, pp. 57-70
Closed Access | Times Cited: 20
Recent advancements in Point-of-Care Detection of Contaminants and Biomarkers in Human Breast Milk: a comprehensive review
SakthiKandan Janakiraman, Rinky Sha, Naresh Kumar Mani
Sensors and Actuators Reports (2025), pp. 100280-100280
Open Access
Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in Africa
Robin Schaefer, Liam Donaldson, A Chigome, et al.
Drug Safety (2025)
Open Access
PregMedNet: Multifaceted Maternal Medication Impacts on Neonatal Complications
Yeasul Kim, Ivana Marić, Chloe M. Kashiwagi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Advancements and challenges in pediatric pharmacotherapy: A comprehensive review
Tahir Bashir Khan
Global Journal of Health Sciences and Research (2025), pp. 1-3
Closed Access
‘I'm glad my baby has weaned so I don't need to make that decision.’ Understanding breastfeeding‐related COVID‐19 vaccine narratives on social media
Becky K White, Sharyn Burns, Jennie Carson, et al.
Health Promotion Journal of Australia (2025) Vol. 36, Iss. 2
Open Access
Efficacy and Safety of Antivirals in Lactating Women with Herpesviridae Infections: A Systematic Review
Vasiliki Kallia, Georgios Schinas, Georgios Karagiannopoulos, et al.
Viruses (2025) Vol. 17, Iss. 4, pp. 538-538
Open Access
Placental Drug Delivery to Treat Pre‐Eclampsia and Fetal Growth Restriction
Venkataraman Deepak, Lujain El‐Balawi, Lynda K. Harris
Small (2024)
Open Access | Times Cited: 3
Perceived barriers and facilitators for model-informed dosing in pregnancy: a qualitative study across healthcare practitioners and pregnant women
Charlotte Koldeweij, Mirèse Kleuskens, Carlijn H. C. Litjens, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
A close examination of BCRP's role in lactation and methods for predicting drug distribution into milk
Caroline Sychterz, Hong Shen, Yueping Zhang, et al.
CPT Pharmacometrics & Systems Pharmacology (2024)
Open Access | Times Cited: 3
Exclusion of pregnant and lactating persons from breast cancer clinical trials: a review of active trials registered on ClinicalTrials.gov
Amy Metcalfe, Nikki Stephenson, Zoe F. Cairncross, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2023) Vol. 103, Iss. 4, pp. 707-715
Open Access | Times Cited: 8
Willingness-to-use and preferences for model-informed antenatal doses: a cross-sectional study among European healthcare practitioners and pregnant women
Charlotte Koldeweij, Anna Caroline Dibbets, Michael Ceulemans, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature
Yanping Li, Yuanlin Wu, Tingting Jiang, et al.
Therapeutic Advances in Drug Safety (2023) Vol. 14
Open Access | Times Cited: 6
Clinical and population‐based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy
Sean S. Brummel, Jeff Stringer, Ed Mills, et al.
Journal of the International AIDS Society (2022) Vol. 25, Iss. S2
Open Access | Times Cited: 9
Protected from harm, harmed by protection: ethical consequences of the exclusion of pregnant participants from clinical trials
Rebecca L. Zur
Research Ethics (2023) Vol. 19, Iss. 4, pp. 536-545
Open Access | Times Cited: 5
The dosing regimen for 17-hydroxyprogesterone caproate was suboptimal: lessons for future pharmacotherapy for pregnant women
Steve N. Caritis, Prerna Dodeja, Shringi Sharma, et al.
American Journal of Obstetrics and Gynecology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top